Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018

FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers

MRI scanner features Siemens’ BioMatrix technology to reduce variations in patient imaging; new applications such as SMS TSE reduce scan times up to 46 percent

FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers

October 9, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI) scanner from Siemens Healthineers that brings Siemens’ BioMatrix technology to the 1.5T market. This technology addresses patient anatomical and physiological differences, as well as differences in how users set up and conduct MRI exams, to increase productivity and decrease rescans for improved efficiency and patient satisfaction.

The Magnetom Sola helps healthcare providers perform a full range of routine and complex MRI exams while accelerating workflow and delivering consistent results across all patient types. BioMatrix Sensors save setup time and inform the correct exam strategy. Respiratory Sensors in the patient table eliminate the need for navigators with respiratory-triggered sequences. A new Kinetic Sensor, an in-bore camera system, enables technologists to visually monitor the patient’s face. BioMatrix Tuners improve the quality and reproducibility of head, neck and spine imaging using distortion-mitigating software and hardware. BioMatrix Interfaces utilize artificial intelligence (AI) and body models to expedite patient positioning and deliver consistent, reproducible results.

The scanner architecture offers extremely high performance in an open, 70-cm bore. Larger body regions can be covered in one step with a full 50x50x50 cm field of view. Ultra-lightweight, anatomy-adaptive coils improve patient comfort while delivering high signal-to-noise ratio with up to 204 RF channels.

New software enables faster scanning to benefit patients and the facility. Multi-Slice TSE reduces routine musculoskeletal scan times by up to 46 percent. Compressed Sensing not only makes cardiac and dynamic liver exams faster, but also enables imaging of patients who cannot reliably hold their breath.

Combined with Dot workflow engines and Tim 4G technology, the software accelerates scanning from positioning to post-processing with continual quality control of image data. The result is increased productivity and consistency across patients and exams.

A cardiovascular edition of the Magnetom Sola – which includes high-performance hardware and software such as Compressed Sensing Cardiac Cine, MyoMaps and the Cardiac Dot engine – is also available.

For more information: www.usa.healthcare.siemens.com


Related Content

News | Cardiac Imaging

Aug. 12, 2026 — Salus Scientific has launched its Clinical Insights Series, a new publication platform designed to share ...

Home August 17, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Ventripoint Diagnostics is expanding subscription-based access to its VMS+ 4.0, its FDA-cleared platform ...

Home August 14, 2026
Home
News | Cardiac Imaging

August 4, 2026 - Epsilon Imaging and ASCEND Cardiovascular have announced a strategic non-exclusive partnership designed ...

Home August 13, 2026
Home
Feature | Cardiac Imaging | John Memarian

The last few decades have been marked by rapid advances in cardiovascular medicine, particularly in areas like imaging ...

Home August 06, 2026
Home
News | Cardiac Imaging

August 3, 2026 — Despite improvements in technology and awareness, work-related musculoskeletal disorders (WRMSDs) ...

Home August 03, 2026
Home
News | Cardiac Imaging

June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...

Home June 12, 2026
Home
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Home May 21, 2026
Home
News | Cardiac Imaging

May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...

Home May 12, 2026
Home
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Home April 29, 2026
Home
News | Cardiac Imaging

April 23, 2026 — Royal Philips has launched the next-generation Bridge Plus Occlusion Balloon, designed to help ...

Home April 23, 2026
Home
Subscribe Now